Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives

Antibody–drug conjugates (ADCs) are complex chemical structures composed of a monoclonal antibody, serving as a link to target cells, which is conjugated with a potent cytotoxic drug (i.e., payload) through a chemical linker. Inspired by Paul Ehrlich’s concept of the ideal anticancer drug as a “magi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sganga, Stefano, Riondino, Silvia, Iannantuono, Giovanni Maria, Rosenfeld, Roberto, Roselli, Mario, Torino, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532725/
https://www.ncbi.nlm.nih.gov/pubmed/37763107
http://dx.doi.org/10.3390/jpm13091339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532725/
https://www.ncbi.nlm.nih.gov/pubmed/37763107
http://dx.doi.org/10.3390/jpm13091339

Ejemplares similares